Loading company…
VitaGen, Inc. is a biotechnology company developing an artificial liver intended for use until a transplant is performed.
VitaGen, Inc. is a biotechnology company in the US focused on developing an artificial liver that would support patients until they receive a transplant. Its stage is recorded as Series C.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in